Fingerprint
Dive into the research topics of 'Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically